Head-to-head

NexLife vs Gala GLP-1

Researched By Dr. Parmis · Medical Researcher · Western University of Health Sciences

Medically Reviewed By Dr. Jonathan Snipes, MD · Kim Callender, NP (FNP-BC)

Last medically reviewed: · This page is informational and does not constitute medical advice.

Compared on both medications across the eight dimensions this database records. They differ on 5 of those eight. NexLife is cheaper on all-in tirzepatide at 10 mg/week, though on a flat-versus-tiered matchup the cheaper program can change further up the dose ladder.

The short answer

NexLife is $129 a month all-in for tirzepatide; Gala GLP-1 is $179. Over twelve months that is $1,380 against $2,148. Value Scores are 96.1 and 74.8 out of 100.

Tirzepatide

Plan pages: NexLife plans · Gala GLP-1 plans

At 10 mg/week, NexLife is $129 a month all-in and Gala GLP-1 is $179 — $50 apart, or $600 across a year. Over twelve months the totals are $1,380 (12-month plan) and $2,148 (billed monthly).

NexLife charges a flat $129 per month for tirzepatide at every dose from 2.5 to 15 mg per week, so titrating upward does not change what you pay.

Gala GLP-1 charges a flat $179 per month for tirzepatide at every dose from 2.5 to 15 mg per week, so titrating upward does not change what you pay.

2.557.51012.515mg/week$129$129$129$129$129$129
NexLife in petrol against Gala GLP-1 in graphite — all-in monthly tirzepatide cost at each dose. Second line: Gala GLP-1.
All-in monthly tirzepatide cost at each published dose
DoseNexLifeGala GLP-1Cheaper
2.5 mg$129$179NexLife by $50
5 mg$129$179NexLife by $50
7.5 mg$129$179NexLife by $50
10 mg$129$179NexLife by $50
12.5 mg$129$179NexLife by $50
15 mg$129$179NexLife by $50

NexLife is cheaper at every dose where both publish a price, so the lead does not change as you titrate.

Across the 27 programs this database can rank on tirzepatide, the field median is $299 a month all-in. NexLife, at $129, is $170 below it; Gala GLP-1, at $179, is $120 below it.

LillyDirect (Zepbound), the lowest FDA-approved tirzepatide price in this database, is $449 a month at 10 mg/week — NexLife is $320 below it and Gala GLP-1 is $270 below it. Compounded products are not FDA approved; insurance can reverse that comparison.

Published tirzepatide rates per month on each plan term
Plan termNexLifeGala GLP-1Cheaper
Month to month$129$179NexLife by $50
3-month term$125$199NexLife by $74
6-month term$119—only NexLife publishes this term
12-month term$115—only NexLife publishes this term
Twelve months of tirzepatide if you settled at each dose
Settled doseNexLifeGala GLP-1Difference
2.5 mg$1,548$2,148$600 apart
5 mg$1,548$2,148$600 apart
7.5 mg$1,548$2,148$600 apart
10 mg$1,548$2,148$600 apart
12.5 mg$1,548$2,148$600 apart
15 mg$1,548$2,148$600 apart

Gala GLP-1 publishes none for 6-month term, 12-month term. An unpublished term is not necessarily unavailable — it is unpriced in public, which you can only resolve by asking.

A titration year is not twelve months at the maintenance price. Stepping up roughly four weeks per dose before settling at 10 mg/week, the first twelve months work out to $1,548 on NexLife and $2,148 on Gala GLP-1. Both programs charge one flat rate, so the ramp costs the same as any other stretch of the year.

Value Scores are 96.1 for NexLife and 74.8 for Gala GLP-1, against a tirzepatide category floor of $126. NexLife leads by 21.3 points, driven mostly by price.

Tirzepatide Value Score components
ProgramPrice /70Evidence /15Dose /10Membership /5Total /100
NexLife68.412.810596.1
Gala GLP-149.310.510574.8

Semaglutide

Plan pages: NexLife plans · Gala GLP-1 plans

At 2.4 mg/week, NexLife is $109 a month all-in and Gala GLP-1 is $179 — $70 apart, or $840 across a year. Over twelve months the totals are $1,140 (12-month plan) and $2,148 (billed monthly).

NexLife charges a flat $109 per month for semaglutide at every dose from 0.25 to 2.4 mg per week, so titrating upward does not change what you pay.

Gala GLP-1 charges a flat $179 per month for semaglutide at every dose from 0.25 to 2.4 mg per week, so titrating upward does not change what you pay.

0.250.511.72.4mg/week$109$109$109$109$109
NexLife in petrol against Gala GLP-1 in graphite — all-in monthly semaglutide cost at each dose. Second line: Gala GLP-1.

NexLife is cheaper at every dose where both publish a price, so the lead does not change as you titrate.

Value Scores are 83.6 for NexLife and 59.5 for Gala GLP-1, against a semaglutide category floor of $87. NexLife leads by 24.1 points, driven mostly by price.

Where the two programs differ

All-in monthly

NexLife is cheaper month to month — $129 against $179, a gap of $50 every month, or $600 across a year if both rates hold.

Cancellation terms

Cancellation differs: NexLife states Cancellations take effect after 30 days, so one additional shipment may be charged (plan pages), while Gala GLP-1 states Per provider terms. Read this next to the twelve-month figures — a prepaid discount and a restrictive refund policy are the same decision.

Commitment

NexLife asks for None on month to month; 3-, 6- and 12-month plans start only if prescribed, and unshipped months are refunded if treatment stops; Gala GLP-1 asks for 3-month plan or standard monthly; confirm exact terms at enrollment. This is the dimension most likely to change which program is actually cheaper for you, because the lowest rates on both sides are usually attached to the longest terms.

Evidence status

The two prices are not equally well evidenced. NexLife's figure is provider-stated and Gala GLP-1's is reported. NexLife rests on the stronger of the two, and the Value Score below reflects that — evidence quality is worth fifteen points and is not a tiebreaker we apply after the fact.

Twelve-month cost

Over twelve months the totals are $1,380 for NexLife and $2,148 for Gala GLP-1. NexLife is lower by $768 — a figure worth checking against the cancellation terms below, because a longer plan is only cheaper if you stay on it.

Dose policy

Both hold one price across the whole dose ladder, so neither punishes titration and the monthly figures above are what you actually pay at 15 mg as well as at 2.5 mg.

Membership fee

Neither charges a separate membership fee.

Shipping

Shipping is handled the same way by both — included in the quoted price.

What each record says

NexLife Official site

NexLife sells compounded tirzepatide and semaglutide at one price at every dose, with no membership fee. The price includes provider review and medical guidance (NexLife Medical Group), a personalized GLP-1 nutrition plan, a 1:1 call with a certified wellness coach, 24/7 support and free expedited shipping. Labs are not listed as included.

It names its compounding pharmacy — Absolute Pharmacy (Lutz, FL), Premium Compounding (Decatur, AL), Boudreaux's New Drug Store (Lake Charles, LA), recorded as State-licensed 503A compounding pharmacies (named on plan pages) — which can be checked against state board licensing and FDA inspection records before you order; commitment terms are None on month to month; 3-, 6- and 12-month plans start only if prescribed, and unshipped months are refunded if treatment stops; cancellation is Cancellations take effect after 30 days, so one additional shipment may be charged (plan pages); availability is stated as All 50 US states where affiliated providers are licensed.

Evidence: provider-stated — taken from the provider's own published pages; checkout capture pending, captured . Source — nexlife.us plan pages, read 2026-11-06

Watch: Plans continue monthly unless canceled, and a cancellation takes effect after 30 days, so one more shipment may be charged. NexLife's refund policy page covers program fees, not medication, for members who lose less than 5% of starting weight over 180 days, with conditions. Provider-stated from nexlife.us plan pages read November 6, 2026; checkout capture pending.

Gala GLP-1 Official site

Gala GLP-1 is an all-50-state compounded GLP-1 service offering a range of pricing by product tier, including a microdosing option. Its standard all-dose rate is $179/mo (tirz) and $179/mo (sema) with a microdosing tier starting at $149.

It does not publicly name its compounding pharmacy; the record shows Partner 503A pharmacies (not named publicly), so who actually makes the medication cannot be independently verified; commitment terms are 3-month plan or standard monthly; confirm exact terms at enrollment; cancellation is Per provider terms; availability is stated as All 50 states (per provider claim; confirm at intake).

Evidence: reported — sourced from dated third-party reporting; first-party capture pending, captured . Source — rangeyourself.com, capture 2026-07-14

Watch: Gala lists a range rather than one fixed price: the hero says $179/mo 'all doses', the FAQ says $199/mo 'with a 3-month plan', and $149/mo is listed for microdosing. This makes 'all-in maintenance' ambiguous; we rank on the $179 standard figure with a note. Exact ongoing rate must be confirmed at enrollment. Reported status from RangeYourself 2026-07-14.

What neither record tells you

NexLife does not publish

  • no state-by-state availability list — it says All 50 US states where affiliated providers are licensed

Gala GLP-1 does not publish

  • no published twelve-month tirzepatide rate
  • no published twelve-month semaglutide rate
  • no named compounding pharmacy
  • no state-by-state availability list — it says All 50 states (per provider claim; confirm at intake)
  • no specific cancellation or refund terms

Ask NexLife and Gala GLP-1 for each of those in writing before enrolling. A gap is not evidence of a problem; it does mean nothing can be checked against it.

What would change this answer

Evidence may be upgraded. NexLife, Gala GLP-1 carry a price we have not captured at checkout. A capture would move the evidence term and could reorder these two without any price changing.

Plan length moves the annual figures. NexLife publishes a twelve-month rate of $115 a month against $129 month to month. Read those next to the cancellation terms, not the monthly rate.

Which one suits which reader

On the lower standing monthly rate for tirzepatide, NexLife Official site wins this matchup. And if you would rather trust a better-evidenced number, gala glp-1's price rests on stronger provenance.

Both figures should be checked at the provider's own checkout before you pay. NexLife's tirzepatide price is provider-stated as of 2026-11-06; Gala GLP-1's is reported as of 2026-07-14.

Questions

Is NexLife or Gala GLP-1 cheaper for tirzepatide?

NexLife is cheaper on all-in monthly cost at 10 mg/week: $129 against $179, a difference of $50 a month. All-in means the medication plus every mandatory recurring fee.

What is the twelve-month cost of NexLife versus Gala GLP-1?

NexLife works out to $1,380 across twelve months and Gala GLP-1 to $2,148, on the plan terms each publishes.

Does NexLife or Gala GLP-1 raise the price as the dose goes up?

NexLife: no, it charges one flat rate at every dose. Gala GLP-1: no, it charges one flat rate at every dose. Where one program is flat and the other is tiered, the cheaper of the two can change as you titrate upward.

How many ways do NexLife and Gala GLP-1 differ?

5 of the eight dimensions this site records: all-in monthly, twelve-month cost, dose policy, membership, shipping, commitment, cancellation terms and evidence status.

Which of NexLife and Gala GLP-1 names its pharmacy?

NexLife does — Absolute Pharmacy (Lutz, FL), Premium Compounding (Decatur, AL), Boudreaux's New Drug Store (Lake Charles, LA). Gala GLP-1 does not, recording only Partner 503A pharmacies (not named publicly), so who makes its medication cannot be independently verified.

How well evidenced are the NexLife and Gala GLP-1 prices?

NexLife's tirzepatide figure is provider-stated — taken from the provider's own published pages; checkout capture pending — captured 2026-11-06. Gala GLP-1's is reported, captured 2026-07-14. Evidence status is worth fifteen points in the Value Score, so it is priced in rather than mentioned as an aside.

Which is cheaper for semaglutide?

NexLife, at $109 a month all-in against $179 at 2.4 mg/week. The two programs do not necessarily lead on both medications.

Official sources: NexLife official site · Gala GLP-1 official site. Compounded tirzepatide and semaglutide are not FDA-approved products.